Miguel Lafarga Selected Research

Miguel Lafarga Research Topics

Disease

8	Neoplasms (Cancer) 01/2020 - 09/2005
7	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021 - 01/2014
4	Oculopharyngeal Muscular Dystrophy 04/2012 - 05/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2015
3	Leukemia 01/2018 - 06/2004
3	Carcinogenesis 10/2016 - 04/2010
3	Colonic Neoplasms (Colon Cancer) 10/2015 - 11/2008
3	Peripheral Nervous System Diseases (PNS Diseases) 06/2014 - 02/2010
3	Breast Neoplasms (Breast Cancer) 03/2007 - 09/2003
2	Muscular Atrophy (Muscle Atrophy) 01/2020 - 09/2019
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2018 - 12/2017
2	Genomic Instability 04/2016 - 10/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 01/2015
2	Carcinoma (Carcinomatosis) 10/2015 - 11/2008
2	Lymphoma (Lymphomas) 01/2015 - 02/2010
2	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2011 - 06/2010
1	Fibrosis (Cirrhosis) 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Neuralgia (Stump Neuralgia) 11/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Atrophy 09/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Infections 11/2020
1	COVID-19 11/2020
1	Muscular Diseases (Myopathy) 09/2020
1	Vitamin D Deficiency 01/2020
1	Aneuploidy (Aneuploid) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Familial encephalopathy with neuroserpin inclusion bodies 01/2018
1	Lafora Disease 01/2018
1	Atkin syndrome 01/2018
1	Guillain-Barre Syndrome 02/2017
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2016
1	Multiple Myeloma 02/2010
1	Neuroinflammatory Diseases 03/2008
1	Alzheimer Disease (Alzheimer's Disease) 01/2006
1	Pleural Effusion (Pleural Effusions) 09/2005
1	Rupture 09/2003

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 09/2021 - 06/2004
4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 10/2011
4	ChromatinIBA 01/2021 - 08/2011
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020 - 03/2007
3	Vitamin D FDA LinkGeneric 01/2020 - 03/2007
3	UbiquitinIBA 06/2014 - 10/2007
3	Bortezomib (Velcade)FDA Link 06/2014 - 02/2010
3	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2014 - 03/2008
3	polyalanineIBA 04/2012 - 03/2008
3	Poly(A)-Binding Protein IIIBA 04/2012 - 03/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2015
2	CateninsIBA 01/2020 - 03/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 04/2016
2	RNA (Ribonucleic Acid)IBA 12/2017 - 10/2016
2	Bexarotene (LGD1069)FDA Link 01/2016 - 01/2015
2	Proteasome InhibitorsIBA 06/2014 - 02/2010
2	Transcription Factors (Transcription Factor)IBA 04/2010 - 11/2008
2	1,25-dihydroxyvitamin DIBA 11/2008 - 03/2007
1	IronIBA 12/2023
1	MethyltransferasesIBA 11/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Amantadine (Aman)FDA LinkGeneric 02/2017
1	CB 3717IBA 04/2016
1	RetinoidsIBA 01/2016
1	CystatinsIBA 10/2015
1	Peptide Hydrolases (Proteases)FDA Link 10/2015
1	Carrier Proteins (Binding Protein)IBA 03/2015
1	Aldehyde DehydrogenaseIBA 03/2015
1	Neuroprotective AgentsIBA 01/2015
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2015
1	Protein AggregatesIBA 06/2014
1	Antineoplastic Agents (Antineoplastics)IBA 06/2014
1	Histone Deacetylase InhibitorsIBA 01/2014
1	A-Form DNA (A-DNA)IBA 06/2010
1	DipeptidesIBA 02/2010
1	Boronic AcidsIBA 02/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2008
1	Protein Synthesis InhibitorsIBA 03/2008
1	Cadherins (E-Cadherin)IBA 03/2007
1	TubulinIBA 01/2006
1	Cetuximab (Erbitux)FDA Link 09/2005
1	Blocking AntibodiesIBA 09/2005
1	Epidermal Growth Factor (EGF)IBA 09/2005
1	Trastuzumab (Herceptin)FDA Link 09/2005
1	Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA 05/2005
1	SDMIBA 06/2004
1	kahalalide FIBA 09/2003

Therapy/Procedure

3	Therapeutics 11/2020 - 01/2014
1	Denervation 09/2020
1	Drug Therapy (Chemotherapy) 09/2005
1	Lasers (Laser) 09/2003